THE MEDULLIPIN SYSTEM OF BLOOD-PRESSURE CONTROL

被引：26

作者：

MUIRHEAD, EE

机构：

[1] The Departments of Pathology, The University of Tennessee, Memphis and Baptist Memorial Hospital, Memphis

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1991年 / 4卷 / 10期

关键词：

RENOMEDULLARY INTERSTITIAL CELLS; MEDULLIPIN-I AND MEDULLIPIN-II; 1-KIDNEY; 1-CLIP HYPERTENSION; LIVER; CYTOCHROME P-450;

D O I：

10.1093/ajh/4.10.556S

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

The medullipin system of BP control has its cellular component in the renomedullary interstitial cells (RICs) of the renal papilla. The RICs secrete medullipin I which is conveyed to the liver to be activated into Med II. This activation appears to involve the cytochrome P-450 dependent enzyme system of the liver. Med II is a vasodilator that suppresses sympathetic tone, causes diuresis-natriuresis and has a suppressive effect on the central nervous system (CNS). As such, Med II has biologic actions the exact opposite of major actions of the renin-angiotensin system. Angiotensin II is a vasoconstrictor that facilitates sympathetic tone, causes salt water retention by the kidney and has stimulatory effect on the CNS. These are double feedback BP control systems. One elevates the BP and is prohypertensive; the other lowers BP and is antihypertensive. Unclipped (UC) the one-kidney, one-clip hypertensive rat has assisted greatly in elucidating the medullipin system. The support for these contentions are documented in this presentation.

引用

页码：S556 / S568

页数：13

共 58 条

[21]

Brunner H.R., Kirshman J.D., Sealey J.E., Laragh J.H., Hypertension of renal origin: Evidence for two different mechanisms, Science, 174, pp. 1344-1346, (1971)

[22]

Swales J.D., Thurston H., Queiroz F.P., Medina A., Sodium balance during the development of experimental hypertension, J Lab Clin Med, 80, pp. 539-547, (1972)

[23]

Muirhead E.E., Byers L.W., Brooks B., Dowell R., The liver converts the antihypertensive hormone of the kidney: The reno-hepatic axis, Hypertension, 8, (1986)

[24]

Muirhead E.E., Rightsel W.A., Pitcock J.A., Inagami T., The renin-angiotensin system in cultured juxtaglomerular cells, Kidney Hormones, 3, pp. 247-272, (1986)

[25]

Muirhead E.E., Byers L.W., Brooks B., Dowell R., The renohepatic axis of blood pressure control: Further studies, Am J Med Sci, 293, 3, pp. 177-181, (1987)

[26]

Muirhead E.E., Byers L.W., Brooks B., Et al., Effect of cytochrome P-450 induction and inhibition on the antihypertensive function of the kidney, Trans Assoc am Physicians, 100, pp. 196-203, (1987)

[27]

Muirhead E.E., Byers L.W., Capdevila J., Et al., The renal antihypertensive endocrine function: Its relation to cytochrome P-450, J Hypertens, 7, 5, pp. 361-369, (1989)

[28]

Muirhead E.E., Brooks B., Byers L.W., Generation of medullipin II by isolated kidney-liver perfusion in tandem, Hypertension

[29]

Ferris A.E.B., Experimental renal insuffi-ciency produced by partial nephrectomy, Arch Int Med, 49, pp. 767-787, (1932)

[30]

Pitcock J.A., Brown P.S., Brooks B., Et al., Morphometric studies on the rat renal papilla of resistant and sensitive strains in partial nephrectomy salt hypertension, J Hy-Pertens, 2, pp. 419-425, (1984)

← 1 2 3 4 5 6 →